Navigation Links
Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million
Date:6/30/2011

heart failure, CLP1001. We believe CLP1001 has the potential to address a significant need in the cardiovascular market for safe and effective management of electrolyte and fluid levels in patients with CHF."

About CLP1001 in Heart Failure

Sorbent's lead product, CLP1001, is a polymer that has been shown to remove potassium, sodium and fluid with good tolerability in over 100 patients and healthy volunteers. The addition of CLP1001 to the treatment regimen in heart failure patients may address fluid overload and the risk of hyperkalemia related to the use of multiple RAAS (Renin-Angiotensin-Aldosterone System) blockers.

About Congestive Heart Failure

Congestive heart failure is a serious and life-threatening condition that  develops when the heart loses its ability to pump blood efficiently, allowing fluid to accumulate in the lungs, abdominal organs (especially the liver) and peripheral tissues. According to the American Heart Association, approximately 5.7 million people in the U.S. are living with heart failure, a condition that accounts for 1.1 million hospitalizations each year. Heart failure is estimated to cost the U.S. healthcare system over $37 billion annually.

About Sorbent

Sorbent Therapeutics is a private biopharmaceutical company developing therapies for patients requiring targeted cation and fluid removal from the body. The Company is focused on the development of a platform of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, end stage renal disease, chronic kidney disease and hypertension. The Company is headquartered in Sunnyvale, California. For more information, visit www.sorbent.com.


'/>"/>
SOURCE Sorbent Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Allied Healthcare Announces Litholyme(TM) -- New CO2 Absorbent Used in Anesthesia
2. Reportlinker Adds US Enzyme-Linked Immunosorbent Assay (ELISA) Industry
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)...  AbbVie Inc. ("AbbVie") (NYSE / CHX / Euronext Paris ... expiration of its exchange offer to acquire all of the ... p.m., New York City time, on ... AbbVie also voluntarily withdrew its initial Notification and Report Form ... the FTC with additional time to review the proposed transaction.  ...
(Date:4/17/2015)... April 17, 2015 CVS Health Corporation (NYSE: ... on Friday, May 1, 2015, at 8:30 a.m. (EDT) ... financial results. An audio webcast of the ... Relations portion of the CVS Health website for all ... . This webcast will be archived and available on ...
(Date:4/17/2015)... , April 17, 2015  In Detroit, where three ... mortality rate is two and one half times of the ... 6 of 10 infants that die in Detroit ... sobering statistics that Covenant Community Care, a faith-based, charitable non-profit ... poised to change thanks to a charitable donation by Konica ...
Breaking Medicine Technology:AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 4Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 2Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 3Covenant Community Care to Receive Donated SONIMAGE P3 Handheld Ultrasound from Konica Minolta Medical Imaging 4
... daily dosages of milnacipran 100,mg and 200 mg ... pain and other core symptoms associated,with fibromyalgia syndrome ... at the 2007 American College of Rheumatology meeting ... responders in a six-month,study were sustained for up ...
... Repligen Corporation,(Nasdaq: RGEN ) today announced positive results ... formulation of uridine, in patients with bipolar,disorder. This was ... or a placebo twice a day for six-weeks. Patients ... their symptoms at baseline,with the exception of mania for ...
Cached Medicine Technology:Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 2Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 3Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 4Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 5Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 6Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 7Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show 8Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder 2Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder 3Repligen Reports Positive Phase 2a Clinical Trial Results of RG2417 for Symptoms of Bipolar Disorder 4
(Date:4/18/2015)... "I recognized the need for a ... said an inventor from Cincinnati, Ohio. "This need inspired ... developed the Slyde Door to offer an alternative to ... It provides convenient storage space for an evacuation stretcher. ... for patients. , This offers added peace of ...
(Date:4/18/2015)... April 18, 2015 Lower-auto-insurance.com has released ... accurate auto insurance quotes . , Drivers ... by comparing quotes. A professional insurance brokerage website can ... quotes, in a simple, convenient way. The whole process ... anyone. , Comparing online car insurance quotes is ...
(Date:4/18/2015)... York, NY (PRWEB) April 18, 2015 On ... Internal Security Threat Report , which they say, “exposes a ... how many new malware variants were introduced in 2014 - ... took for Zero Day threats to be identified and patched ... it is abundantly clear that doing business in a digital ...
(Date:4/17/2015)... (PRWEB) April 18, 2015 Heritage Woods ... begin its Supportive Living Week Celebration on April 20 ... having a healthy mind, body and soul. , The ... McLeansboro, Illinois, serves older adults of all incomes, including ... their independence. , Supportive Living Week is observed every ...
(Date:4/17/2015)... Alcohol and Violence , The National Council ... and driving has been the focus of much public ... link between alcohol and crime received less public attention. ... sexual assault, and their relationship to alcohol have been ... adults in America were drinking alcohol at the time ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes Can Provide Accurate Results! 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3
... than Canada, study finds , THURSDAY, Feb. 25 (HealthDay ... among women, explain why arthritis is more common in ... new study. , Researchers at the Toronto Western Research ... that the prevalence of arthritis in the United States ...
... ... healthcare performance management strategies are the way to more effectively control healthcare costs across ... ... the Healthcare Performance Management (HPM) Institute, WellNet today expressed its support for -- and ...
... ... a leading medical informatics company, has launched a new enterprise platform for its revolutionary ... 5 systems., , ... Milwaukee, WI (PRWEB) February 25, 2010 -- TeraMedica Healthcare Technology , a leading ...
... ... RTLS Technology Platform strengthen further the technology’s position as the ultraSound choice for ... ... world leader in ultrasound-based real time locating systems for hospitals and long-term care ...
... ... ... , ... , , ...
... Advanced cancer patients who regularly received massages averaging 14 ... in stress scores over four weeks, according to results of ... American Psychosocial Oncology Society. In the study, sponsored by ... of a DVD program to provide massage to patients at ...
Cached Medicine News:Health News:WellNet Supports HPM Institute Director in Calling for More Active Enterprise Involvement in Managing Healthcare Quality and Costs 2Health News:TeraMedica Launches Evercore – Clinical Enterprise Suite 5.0 Now on Linux 2Health News:Sonitor Technologies Announces New Staff Tag and Battery Powered Ultrasound Receiver 2Health News:Catholic Charities USA Calls for Affordable and Accessible Healthcare for All 2Health News:Catholic Charities USA Calls for Affordable and Accessible Healthcare for All 3Health News:Family members reduce stress in advanced cancer patients with 14 minute massages 2
... Olympus is proud to announce the next ... a good thing even better.,Now you have ... The CYF-4 and CYF-4A feature improved optics, ... smoother insertion of instruments. In addition, the ...
... Thermotherapy™ is an advanced transurethral microwave ... of benign prostate hyperplasia (BPH). TherMatrx ... BPH thermotherapy treatment in the United ... TherMatrx does not require cutting, heavy ...
... release of the OES Pro line of One-Piece ... commonly used cystoscopy sheaths has taken Olympus Rigid ... have one instrument that performs it all. Thanks ... offer a superior channel size while maintaining the ...
Fast, accurate SpO2 measurements always within reach....
Medicine Products: